Literature DB >> 23382519

Experimental activation of the sphenopalatine ganglion provokes cluster-like attacks in humans.

Henrik W Schytz1, Mads Barløse, Song Guo, Juliette Selb, Anthony Caparso, Rigmor Jensen, Messoud Ashina.   

Abstract

BACKGROUND: High frequency (HF) stimulation of the sphenopalatine ganglion (SPG) is an emerging abortive treatment for cluster headache (CH) attacks. HF SPG stimulation is thought to exert its effect by physiologically blocking parasympathetic outflow. We hypothesized that low frequency (LF) SPG stimulation may activate the SPG, causing increased parasympathetic outflow and thereby provoking cluster attacks in CH patients.
METHODS: In a double-blind randomized cross-over study, seven CH patients implanted with an SPG neurostimulator were randomly allocated to receive HF or LF stimulation for 3 min on 2 separate days. We recorded headache characteristics and autonomic symptoms during and after stimulation.
RESULTS: Six patients completed the study. Three out of six patients (50%) reported ipsilateral cluster-like attacks during or within 30 min of LF SPG stimulation. These cluster-like attacks were all successfully treated with the therapeutic HF SPG stimulation. One out of six reported a cluster-like attack with 3 min HF SPG stimulation, which was also successfully treated with continued HF therapeutic SPG stimulation. DISCUSSION: LF SPG stimulation may induce cluster-like attacks with autonomic features, which can subsequently be treated by HF SPG stimulation. Efferent parasympathetic outflow from the SPG may initiate autonomic symptoms and activate trigeminovascular sensory afferents, which may initiate the onset of pain associated with CH.

Entities:  

Keywords:  Cluster headache; autonomic nervous system; headache model; neurostimulation; sphenopalatine ganglion

Mesh:

Year:  2013        PMID: 23382519     DOI: 10.1177/0333102413476370

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  24 in total

Review 1.  Neurostimulation at pterygopalatine fossa for cluster headaches and cerebrovascular disorders.

Authors:  Samer Narouze
Journal:  Curr Pain Headache Rep       Date:  2014-07

Review 2.  Central and Peripheral Neural Targets for Neurostimulation of Chronic Headaches.

Authors:  Massimo Leone; Alberto Proietti Cecchini
Journal:  Curr Pain Headache Rep       Date:  2017-03

Review 3.  Neuromodulation for intractable headaches.

Authors:  Roya Hassanzadeh; Jeremy C Jones; Edgar L Ross
Journal:  Curr Pain Headache Rep       Date:  2014-02

4.  Visually stressful striped patterns alter human visual cortical functional connectivity.

Authors:  Jie Huang; David C Zhu
Journal:  Hum Brain Mapp       Date:  2017-07-31       Impact factor: 5.038

Review 5.  Neurostimulation methods in the treatment of chronic pain.

Authors:  X Moisset; M Lanteri-Minet; D Fontaine
Journal:  J Neural Transm (Vienna)       Date:  2019-10-21       Impact factor: 3.575

Review 6.  The pipeline in headache therapy.

Authors:  Sarah Vollbracht; Alan M Rapoport
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

7.  Alcohol percutaneous neurolysis of the sphenopalatine ganglion in the management of refractory cranio-facial pain.

Authors:  Adrian Kastler; Gilles Cadel; Alexandre Comte; Guillaume Gory; Veronique Piccand; Laurent Tavernier; Bruno Kastler
Journal:  Neuroradiology       Date:  2014-04-26       Impact factor: 2.804

Review 8.  A new era in headache treatment.

Authors:  Michail Vikelis; Konstantinos C Spingos; Alan M Rapoport
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

Review 9.  Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment.

Authors:  Håkan Ashina; Lawrence Newman; Sait Ashina
Journal:  Neurol Sci       Date:  2017-08-30       Impact factor: 3.307

Review 10.  Invasive and Non-invasive Electrical Pericranial Nerve Stimulation for the Treatment of Chronic Primary Headaches.

Authors:  Kevin D'Ostilio; Delphine Magis
Journal:  Curr Pain Headache Rep       Date:  2016-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.